Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2024.02.015 ↗Kurz gefasst
Editorial in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Gabriele Capurso und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pancreatobiliary Endoscopy and Endosonography Division, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, M…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Pancreatitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pancreatobiliary Endoscopy and Endosonography Division, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: capurso.gabriele@hsr.it.
- Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Zitieren
APA
Capurso, G., & Malesci, A. (2024). Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.02.015
Vancouver
Capurso G, Malesci A. Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.02.015
BibTeX
@article{Capurso2024,
author = {Capurso, Gabriele and Malesci, Alberto},
title = {Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2024.02.015}
}
EUVIMED